These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17869550

  • 1. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
    Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R.
    Blood Cells Mol Dis; 2008; 40(1):25-32. PubMed ID: 17869550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM, Almeida J, López-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC.
    Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y, Deng YB, Huang YJ, Wang Y.
    Immunol Invest; 2008 Dec; 37(1):29-42. PubMed ID: 18214798
    [Abstract] [Full Text] [Related]

  • 8. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
    Larocca A, Piaggio G, Podestà M, Pitto A, Bruno B, Di Grazia C, Gualandi F, Occhini D, Raiola AM, Dominietto A, Bregante S, Lamparelli T, Tedone E, Oneto R, Frassoni F, Van Lint MT, Pogliani E, Bacigalupo A.
    Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
    Zhou H, Guo M, Bian C, Sun Z, Yang Z, Zeng Y, Ai H, Zhao RC.
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
    [Abstract] [Full Text] [Related]

  • 10. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
    Tyndall A, Uccelli A.
    Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
    [Abstract] [Full Text] [Related]

  • 11. [The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation].
    Liu XD, Fan ZP, Peng YW, Huang F, Jiang QL, Zhang X, Yu GP, Zhao J, Sun J, Xiang P, Liu QF.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):98-102. PubMed ID: 22730656
    [Abstract] [Full Text] [Related]

  • 12. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ, McTaggart SJ.
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
    Bernardo ME, Avanzini MA, Ciccocioppo R, Perotti C, Cometa AM, Moretta A, Marconi M, Valli M, Novara F, Bonetti F, Zuffardi O, Maccario R, Corazza GR, Locatelli F.
    Cytotherapy; 2009 Jun; 11(7):825-36. PubMed ID: 19903096
    [Abstract] [Full Text] [Related]

  • 15. Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia.
    Fang B, Li N, Song Y, Li J, Zhao RC, Ma Y.
    Pediatr Transplant; 2009 Jun; 13(4):499-502. PubMed ID: 18673358
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [Abstract] [Full Text] [Related]

  • 18. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
    Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S.
    Cytotherapy; 2009 Jun; 11(7):897-911. PubMed ID: 19903102
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
    Si Y, Yang K, Qin M, Zhang C, Du Z, Zhang X, Liu Y, Yue Y, Feng Z.
    Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
    [Abstract] [Full Text] [Related]

  • 20. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
    Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R.
    Klin Padiatr; 2006 Feb; 218(6):321-6. PubMed ID: 17080334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.